William C Bertrand JR insider trades

Open-market stock purchases and sales by William C Bertrand JR, Director at Ardelyx, Inc, from SEC Form 4 filings since Jul 24, 2013.

Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -86%.

Recent trades

DateStockTradeValue
Jun 16, 2026ARDX Ardelyx, IncBought (not open market)—
Jun 16, 2026ARDX Ardelyx, IncBought (not open market)—
Jun 16, 2026ARDX Ardelyx, IncBought (not open market)—

Companies traded

  • ARDX Ardelyx, Inc: 1 buy, last Jun 16, 2026
  • ADAP Adaptimmune Therapeutics plc: 1 buy, 24 sales, last Aug 28, 2025
  • ADAP] Adaptimmune Therapeutics plc: other filings, last Jan 17, 2023
  • INFI Infinity Pharmaceuticals, Inc: other filings, last Oct 19, 2015
  • SLXP Salix Pharmaceuticals Ltd: other filings, last Apr 1, 2015

Get free alerts when William C Bertrand JR files a new trade →